An Orally Bioavailable c-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth

類似資料

• Cooperation between c-Met and focal adhesion kinase family members in medulloblastoma and implications for therapy
  著者:: Guessous, Fadila, 等
  出版事項: (2011)
• XL-184, a MET, VEGFR-2 and RET kinase inhibitor for the treatment of thyroid cancer, glioblastoma multiforme and NSCLC
  著者:: Zhang, Ying, 等
  出版事項: (2010)
• Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibition
  著者:: Zhang, Ying, 等
  出版事項: (2013)
• microRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes
  著者:: Li, Yunqing, 等
  出版事項: (2009)
• MicroRNA-608 and MicroRNA-34a Regulate Chordoma Malignancy by Targeting EGFR, Bcl-xL and MET
  著者:: Zhang, Ying, 等
  出版事項: (2014)